Brinker Capital Investments, LLC Charles River Laboratories International, Inc. Transaction History

Brinker Capital Investments, LLC

$11.4 Billion
Q3 2025

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Jul 31, 2025	SELL	$150.52 - $190.14 $209,222 - $264,294	-1,390 Closed	0 $0
Q4 2024 Jul 31, 2025	SELL	$178.58 - $220.69 $329,837 - $407,614	-1,847 Reduced 57.06%	1,390 $256,000
Q3 2024 Jul 31, 2025	SELL	$187.96 - $245.29 $12,593 - $16,434	-67 Reduced 2.03%	3,237 $637,000
Q2 2024 Jul 31, 2025	SELL	$206.39 - $268.73 $15,272 - $19,886	-74 Reduced 2.19%	3,304 $682,000
Q1 2024 Jul 31, 2025	SELL	$203.52 - $273.43 $7,733 - $10,390	-38 Reduced 1.11%	3,378 $915,000

Q4 2023 Jul 31, 2025	SELL	$164.52 - $238.84 $99,041 - $143,781	-602 Reduced 14.98%	3,416 $807,000
Q3 2023 Jul 31, 2025	SELL	$194.44 - $217.61 $108,886 - $121,861	-560 Reduced 12.23%	4,018 $787,000
Q2 2023 Jul 31, 2025	SELL	$183.71 - $210.25 $19,656 - $22,496	-107 Reduced 2.28%	4,578 $962,000
Q1 2023 Jul 31, 2025	SELL	$191.89 - $259.92 $90,955 - $123,202	-474 Reduced 9.19%	4,685 $945,000
Q4 2022 Feb 06, 2023	SELL	$197.11 - $250.07 $53,022 - $67,268	-269 Reduced 4.96%	5,159 $1.12 Million
Q3 2022 Nov 01, 2022	BUY	$182.44 - $250.54 $27,183 - $37,330	149 Added 2.82%	5,428 $1.07 Million
Q2 2022 Jul 18, 2022	SELL	$204.13 - $302.4 $129,010 - $191,116	-632 Reduced 10.69%	5,279 $1.13 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $66,688 - $94,510	-261 Reduced 4.23%	5,911 $1.68 Million
Q4 2021 Feb 08, 2022	BUY	$351.38 - $448.68 $365,786 - $467,075	1,041 Added 20.29%	6,172 $2.33 Million
Q2 2021 Aug 03, 2021	SELL	$294.17 - $371.65 $154,439 - $195,116	-525 Reduced 9.28%	5,131 $1.9 Million
Q1 2021 May 12, 2021	SELL	$249.67 - $299.48 $456,396 - $547,449	-1,828 Reduced 24.43%	5,656 $1.64 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $750,138 - $853,602	3,379 Added 82.31%	7,484 $1.87 Million
Q3 2020 Dec 03, 2020	BUY	$175.56 - $226.45 $720,673 - $929,577	4,105 New	4,105 $930,000

Others Institutions Holding CRL

# of Institutions

646

Shares Held

51.7M

Call Options Held

194K

Put Options Held

174K

Vanguard Group Inc Valley Forge, PA

5.84M
Shares

$980 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$854 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.19M
Shares

$535 Million
0.09% of portfolio
Allspring Global Investments Holdings, LLC

2M
Shares

$335 Million
0.62% of portfolio
State Street Corp Boston, MA

1.83M
Shares

$307 Million
0.01% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.54B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account